Therapeutic Drug Monitoring Market - By Product (Consumables And Equipment), By Technology (Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Agents, And Other), By End User (Pharmaceutical Companies, Hospitals & Clinics, Medical Device Companies, Food & Beverage Companies, And Other) And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 191
Status: Published
Report Code: ARI100440
Therapeutic drug monitoring end users include the diagnosis of unexpected complications, such as toxicity, and the identification and subsequent tailoring of the optimal drug dose specific to the genetic profile of the concerned patient. In addition, TDM finds its end user in diagnosing the root cause of failed therapy outcomes in a precise manner as it enables physicians to draw distinctions between the following confounding outcomes: ineffectual drug treatments, patient medication non-compliance, and adverse drug reactions that may be synonymous with the effects of the underlying condition. The increasing demand for the administration of personalized dosage patterns is expected to favour the emergence of the TDM market during the forecast period.
The introduction of novel devices with marked technological advancements facilitates rapid throughput operations with increased accuracy and specificity. The new range of the automated devices, such as IMMULITE 2000 XPiimmunoassay system, is expected to further drive the market growth.
A clinical chemistry analyser, on average, costs between USD 200,000 and USD 600,000. While fully automated analysers are available at low prices, the variable costs of the reagents needed, and those fixed by the suppliers thereof, add to the overall expenditure. Furthermore, maintenance and insurance, laboratory supervision, and overhead (including utilities, space, and administration) are also additional expenses
The major players operating in the therapeutic drug monitoring market include Abbott Laboratories (U.S.), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux (France), BÜHLMANN Laboratories (Switzerland), SEKISUI MEDICAL (Japan), Randox Laboratories (Ireland), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (United Kingdom), ARK Diagnostics, Inc. (U.S.), Chromsystems Instruments & Chemicals GmbH (Germany), Grifols (Spain), Exagen Inc. (U.S.), Theradiag (France), R-Biopharm AG (Germany), apDia Group (Belgium), BioTeZ Berlin-Buch GmbH (Belgium), Eagle Biosciences Inc. (U.S.), JASEM Laboratory Systems and Solutions A.S (Turkey), Aalto Scientific (U.S.), Immundiagnostik AG (Germany),and UTAK (U.S.).
Analyst Commentary
On the basis of technology, Antiepileptics are the most commonly monitored class of drugs due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.
Based on end user, Hospitals & clinics accounted for the largest share of the therapeutic drug monitoring market in 2020. The large share of this segment can be attributed to factors such as the increasing incidence of healthcare-associated infections (HAIs), the growing number of hospitals in Asian countries, and the increasing number of surgical procedures performed.
On the basis of product, in 2020, consumables segment accounted for the largest market share, primarily due to the repeat purchases of kits and reagents and the increasing number of immunoassay tests being performed across the globe.
Segmentation
The therapeutic drug monitoring market is segmented based on product, technology, end user and region. Based on end user, the therapeutic drug monitoring market is segmented into pharmaceutical companies, hospitals & clinics, medical device companies, food & beverage companies, and other end users. On the basis of product, the therapeutic drug monitoring market is segmented into consumables and equipment. On the basis of technology, the therapeutic drug monitoring market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs.
Regional Analysis
Geographically, the therapeutic drug monitoring (TDM) market can be segmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. North America is estimated to hold the largest share of the global therapeutic drug monitoring (TDM) market due to the presence of superior health care base, strong regional economics, and greater emphasis on prevention and wellness by government. This trend is also reflected in other countries.
The therapeutic drug monitoring (TDM) market in Europe is expected to witness rapid growth, attributed to high consciousness about wellbeing in the region coupled with increasing spending on healthcare services. Countries such as China, Japan, and India in the Asia Pacific are poised to be the most promising markets for therapeutic drug monitoring (TDM) in the near future. Major factors for the positive outlook are extensive development of health care infrastructure, and growing emphasis on research and development in the health care sector.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Therapeutic Drug Monitoring Market
Chapter 5. Global Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
5.1. Global Therapeutic Drug Monitoring Market Share, By Product, 2020 & 2027 (%)
5.1.1. Consumable
5.1.1.1. Market Size and Projections,2015 - 2027(USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.2. Equipment
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 6. Global Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
6.1. Global Therapeutic Drug Monitoring Market Share, By Technology, 2020 & 2027 (%)
6.1.1. Antiepileptic Drugs
6.1.1.1. Market Size and Projections,2015 - 2027(USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.2. Antibiotic Drugs
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.3. Immunosuppressant Drugs
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.4. Antiarrhythmic Drugs
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.5. Bronchodilator Drugs
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.6. Psychoactive Drugs
6.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.6.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.7. Others
6.1.7.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.7.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 7. Global Therapeutic Drug Monitoring Market Overview, By End User, 2015 - 2027(USD Million)
7.1. Global Therapeutic Drug Monitoring Market Share, By End User, 2020 & 2027 (%)
7.1.1. Pharmaceutical Companies
7.1.1.1. Market Size and Projections,2015 - 2027(USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.2. Hospitals & Clinics
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.3. Medical Device Companies
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.4. Food & Beverage Companies
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.5. Others
7.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 8. Global Therapeutic Drug Monitoring Market Overview, By Geography, 2015 - 2027(USD Million)
8.1. Global Therapeutic Drug Monitoring Market Share, By Geography, 2020 - 2027(%)
8.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2018 (%)
Chapter 9. North America Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. North America Therapeutic Drug Monitoring Market Overview, 2020 & 2027 (%)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. North America Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
9.1.3. North America Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027 (USD Million)
9.1.4. North America Therapeutic Drug Monitoring Market Overview, By End Use, 2015 - 2027 (USD Million)
9.1.5. North America Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Therapeutic Drug Monitoring Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027 (USD Million)
9.1.5.1.4. U.S. Therapeutic Drug Monitoring Market Overview, By End Use, 2015 - 2027 (USD Million)
9.1.5.2. Canada Therapeutic Drug Monitoring Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027 (USD Million)
9.1.5.2.4. Canada Therapeutic Drug Monitoring Market Overview, By End Use, 2015 - 2027 (USD Million)
9.1.5.3. Mexico Therapeutic Drug Monitoring Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027 (USD Million)
9.1.5.3.4. Mexico Therapeutic Drug Monitoring Market Overview, By End Use, 2015 - 2027 (USD Million)
Chapter 10. Europe Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Europe Therapeutic Drug Monitoring Market Overview, 2020 & 2027 (%)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027 (USD Million)
10.1.3. Europe Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.3.1. Germany
10.1.3.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.1.2. Germany Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
10.1.3.1.3. Germany Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
10.1.3.1.4. Other Segments
10.1.3.2. France
10.1.3.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.2.2. France Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
10.1.3.2.3. France Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
10.1.3.2.4. Other Segments
10.1.3.3. UK
10.1.3.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.3.2. UK Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
10.1.3.3.3. UK Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
10.1.3.3.4. Others Segments
10.1.3.4. Italy
10.1.3.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.4.2. Italy Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
10.1.3.4.3. Italy Therapeutic Drug Monitoring Market Overview, By Technology 2015 - 2027(USD Million)
10.1.3.4.4. Other Segment
10.1.3.5. Spain
10.1.3.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.5.2. Spain Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
10.1.3.5.3. Spain Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
10.1.3.5.4. Others Segments
10.1.3.6. Rest of Europe
10.1.3.6.1. Market size and projections, 2015 – 2025
10.1.3.6.2. Rest of Europe Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
10.1.3.6.3. Rest of Europe Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
10.1.3.6.4. Other Segments
Chapter 11. Asia Pacific Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027(USD Million)
11.1. Asia Pacific Therapeutic Drug Monitoring Market Overview, 2020 & 2027(%)
11.1.1. Market size and projections, 2015 - 2027(USD Million)
11.1.2. Asia Pacific Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
11.1.3. Asia Pacific Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
11.1.4. Other Segments
11.1.5. Asia Pacific Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027(USD Million)
11.1.5.1. India
11.1.5.1.1. Market size and projections, 2015 - 2027(USD Million)
11.1.5.1.2. India Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.1.3. India Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
11.1.5.2. China
11.1.5.2.1. Market size and projections, 2015 - 2027(USD Million)
11.1.5.2.2. China Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.2.3. China Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market size and projections, 2015 - 2027(USD Million)
11.1.5.3.2. Japan Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.3.3. Japan Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
11.1.5.4. South Korea
11.1.5.4.1. Market size and projections, 2015 - 2027(USD Million)
11.1.5.4.2. South Korea Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.4.3. South Korea Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market size and projections, 2015 - 2027(USD Million)
11.1.5.5.2. Rest of Asia Pacific Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.5.3. Rest of Asia Pacific Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
Chapter 12. Middle East & Africa Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027(USD Million)
12.1. Middle East & Africa Therapeutic Drug Monitoring Market Overview, 2015 - 2027(USD Million)
12.1.1. Market size and projections, 2015 - 2027(USD Million)
12.1.2. Middle East & Africa Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
12.1.3. Middle East & Africa Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
12.1.4. Middle East & Africa Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027(USD Million)
12.1.4.1. GCC
12.1.4.1.1. Market size and projections, 2015 - 2027(USD Million)
12.1.4.1.2. GCC Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
12.1.4.1.3. GCC Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
12.1.4.2. South Africa
12.1.4.2.1. Market size and projections, 2015 - 2027(USD Million)
12.1.4.2.2. South Africa Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
12.1.4.2.3. South Africa Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
12.1.4.3. Rest of Middle East & Africa
12.1.4.3.1. Market size and projections, 2015 - 2027(USD Million)
12.1.4.3.2. Rest of Middle East & Africa Therapeutic Drug Monitoring Market Overview, By, Product 2015 - 2027(USD Million)
12.1.4.3.3. Rest of Middle East & Africa Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
Chapter 13. South America Therapeutic Drug Monitoring Market Overview, By Countries, 2015 - 2027(USD Million)
13.1. South America Therapeutic Drug Monitoring Market Overview, 2015 - 2027(USD Million)
13.1.1. Market size and projections, 2015 - 2027(USD Million)
13.1.2. South America Therapeutic Drug Monitoring Market Overview, By Product 2015 - 2027(USD Million)
13.1.3. South America Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
13.1.4. Other segments
13.1.5. South America Therapeutic Drug Monitoring Market Overview, By Countries, 2015- 2026(USD Million)
13.1.6. Brazil
13.1.6.1. Market size and projections, 2015 - 2027(USD Million)
13.1.6.2. Brazil Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
13.1.6.3. Brazil Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market size and projections, 2015 - 2027(USD Million)
13.1.7.2. Argentina Therapeutic Drug Monitoring Market Overview, By Product, 2015 - 2027(USD Million)
13.1.7.3. Argentina Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market size and projections, 2015 – 2026
13.1.8.2. Rest of South America Therapeutic Drug Monitoring Market Overview, By Product , 2015 - 2027(USD Million)
13.1.8.3. Rest of South America Therapeutic Drug Monitoring Market Overview, By Technology, 2015 - 2027(USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New product development
Chapter 15. Key Vendor Analysis
15.1. Abbott Laboratories
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Hoffmann-La Rochhe
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Thermo fisher scientific
15.4. J & K Scientific Ltd.
Chapter 16. Therapeutic Drug Monitoring Market Cost Analysis
16.1. Therapeutic Drug Monitoring Market Key Raw Materials Analysis
16.1.1. Key Raw Materials
16.1.2. Price Trend of Key Raw Materials
16.1.3. Key Suppliers of Raw Materials
16.1.4. Market Concentration Rate of Raw Materials
16.2. Proportion of Isophthalic Resin Cost Structure
16.2.1. Raw Materials
16.2.2. Labor Cost
16.2.3. Isophthalic Resin Expenses
16.3. Isophthalic Resin Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Therapeutic Drug Monitoring Market Industrial Chain Analysis
17.2. Upstream Raw Materials Sourcing
17.3. Raw Materials Sources of Therapeutic Drug Monitoring Market Major Manufacturers in 2019
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Industry
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Therapeutic Drug Monitoring Market share, by Product, 2020 & 2027 (%)
10. Global Therapeutic Drug Monitoring Market, by Consumable, by Product, 2015 - 2027(USD Million)
11. Global Therapeutic Drug Monitoring Market, by Equipment, by Product 2015 - 2027(USD Million)
12. Global Therapeutic Drug Monitoring Market share, by Technology, 2020 & 2027 (%)
13. Global Therapeutic Drug Monitoring Market share, by Antiepileptic Drugs, by Technology, 2015 - 2027(USD Million)
14. Global Therapeutic Drug Monitoring Market share, by Antibiotic Drugs, by Technology, 2015 - 2027(USD Million)
15. Global Therapeutic Drug Monitoring Market share, by Immunosuppressant Drugs, by Technology, 2015 - 2027(USD Million)
16. Global Therapeutic Drug Monitoring Market share, by Antiarrhythmic Drugs, by Technology, 2015 - 2027(USD Million)
17. Global Therapeutic Drug Monitoring Market share, by Bronchodilator Drugs, by Technology, 2015 - 2027(USD Million)
18. Global Therapeutic Drug Monitoring Market share, by Psychoactive Agents, by Technology, 2015 - 2027(USD Million)
19. Global Therapeutic Drug Monitoring Market share, by Others, by Technology, 2015 - 2027(USD Million)
20. Global Therapeutic Drug Monitoring Market share, by End Use, 2020 & 2027 (%)
21. Global Therapeutic Drug Monitoring Market share, by Pharmaceutical Companies, by End Use, 2015 - 2027(USD Million)
22. Global Therapeutic Drug Monitoring Market share, by Hospitals & Clinics, by End Use, 2015 - 2027(USD Million)
23. Global Therapeutic Drug Monitoring Market share, by Medical Device Companies, by End Use, 2015 - 2027(USD Million)
24. Global Therapeutic Drug Monitoring Market share, by Food & Beverage Companies, by End Use, 2015 - 2027(USD Million)
25. Global Therapeutic Drug Monitoring Market share, by Others, by End Use, 2015 - 2027(USD Million)
26. Global Therapeutic Drug Monitoring Market share, by region, 2020 & 2027 (%)
27. North America Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
28. North America Therapeutic Drug Monitoring Market share, by Countries, 2020 & 2027 (%)
29. U.S. Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
30. Canada Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
31. Europe Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
32. Europe Therapeutic Drug Monitoring Market share, by Countries, 2020 & 2027 (%)
33. Spain Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
34. UK Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
35. Italy Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
36. Germany Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
37. France Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
38. Rest of Europe Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
39. Asia-Pacific Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
40. Asia-Pacific Therapeutic Drug Monitoring Market share, by Countries, 2020 & 2027 (%)
41. China Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
42. India Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
43. Australia Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
44. Japan Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
45. Rest of Asia-Pacific Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
46. Middle East & Africa Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
47. Middle East & Africa Therapeutic Drug Monitoring Market share, by Countries, 2020 & 2027 (%)
48. GCC Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
49. South Africa Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
50. Rest Of Middle East & Africa Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
51. South America Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
52. Brazil Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
53. Mexico Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
54. Argentina Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
55. Rest of South America Therapeutic Drug Monitoring Market, 2020 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Therapeutic Drug Monitoring Market, 2015-2027(USD Million)
4. Global Therapeutic Drug Monitoring Market requirement, by country, 2015-2027,(USD Million)
5. North America Therapeutic Drug Monitoring Market, by Product, 2015-2027(USD Million)
6. North America Therapeutic Drug Monitoring Market, by Technology 2015-2027(USD Million)
7. North America Therapeutic Drug Monitoring Market, by End Use 2015-2027(USD Million)
8. Europe Therapeutic Drug Monitoring Market, by Product, 2015-2027(USD Million)
9. Europe Therapeutic Drug Monitoring Market, by Technology, 2015-2027(USD Million)
10. Europe Therapeutic Drug Monitoring Market, by End Use, 2015-2027(USD Million)
11. Asia Pacific Therapeutic Drug Monitoring Market, by Product, 2015-2027(USD Million)
12. Asia Pacific Therapeutic Drug Monitoring Market, by Technology, 2015-2027(USD Million)
13. Asia Pacific Therapeutic Drug Monitoring Market, by End Use, 2015-2027(USD Million)
14. Middle East & Africa Therapeutic Drug Monitoring Market, by Product, 2015-2027(USD Million)
15. Middle East & Africa Therapeutic Drug Monitoring Market, by Technology, 2015-2027(USD Million)
16. Middle East & Africa Therapeutic Drug Monitoring Market, by End Use, 2015-2027(USD Million)
17. South America Therapeutic Drug Monitoring Market, by Product, 2015-2027(USD Million)
18. South America Therapeutic Drug Monitoring Market, by Technology, 2015-2027(USD Million)
19. South America Therapeutic Drug Monitoring Market, by End Use, 2015-2027(USD Million)
20. Global Therapeutic Drug Monitoring Market, Company Market Share, 2018 (%)
21. Abbott Laboratories: Product Benchmarking
22. Abbott Laboratories: Financial Performance
23. Hoffmann-La Rochhe: Product Benchmarking
24. Hoffmann-La Rochhe: Financial Performance
25. Thermo fisher scientific: Product Benchmarking
26. Thermo fisher scientific: Financial Performance
27. J & K Scientific Ltd: Product Benchmarking
28. J & K Scientific Ltd: Financial Performance
The Leading Key Players in Therapeutic Drug Monitoring Market
Abbott Laboratories (U.S.)
F. Hoffmann-La Roche (Switzerland)
Siemens Healthineers (Germany)
Thermo Fisher Scientific (U.S.)
Danaher Corporation (U.S.)
Bio-Rad Laboratories (U.S.)
bioMérieux (France)
BÃœHLMANN Laboratories (Switzerland)
SEKISUI MEDICAL (Japan)
Randox Laboratories (Ireland)
DiaSystem Scandinavia AB (Sweden)
Cambridge Life Sciences Limited (United Kingdom)
ARK Diagnostics Inc. (U.S.)
Chromsystems Instruments & Chemicals GmbH (Germany)
Grifols (Spain)
Exagen Inc. (U.S.)
Theradiag (France)
R-Biopharm AG (Germany)
apDia Group (Belgium)
BioTeZ Berlin-Buch GmbH (Belgium)
Eagle Biosciences Inc. (U.S.)
JASEM Laboratory Systems and Solutions A.S (Turkey)
Aalto Scientific (U.S.)
Immundiagnostik AG (Germany),and UTAK (U.S.).
